Current roles. Stephanie Mohr, PhD, is a Lecturer in the Department of Genetics at Harvard Medical School and the Director of DRSC/TRiP-Functional Genomics Resources. She additionally serves as Director of the Dana Farber/Harvard Cancer Center (DF/HCC) Collaborative Functional Genomics Core and DF/HCC DNA Resource Core. Stephanie's expertise spans functional genomics, Drosophila genetics and genomics, high-throughput screening, cell-based assays, lab automation, and bioinformatics. She also has a strong interest in the use of Drosophila to study human diseases and in the cell biology of metal homeostasis and detoxification. Current research projects include a large-scale binary interaction map for Drosophila proteins and use of CRISPR technologies to develop cell and in vivo disease models.
Background. Stephanie received a BA with honors in biology from Wesleyan University and a PhD in molecular, cellular and developmental biology from the University of Colorado at Boulder. She was a postdoctoral fellow in the laboratory of the late Prof. William M. Gelbart in the Department of Molecular and Cellular Biology at Harvard University, then joined the Harvard Institute of Proteomics in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. In 2008, Stephanie became Director of the Drosophila RNAi Screening Center (DRSC), now DRSC/TRiP-FGR, in the Laboratory of Prof. Norbert Perrimon, Department of Genetics, Harvard Medical School. She has additionally served as Director of the DF/HCC Collaborative Functional Genomics Core since 2010 and Director of the DF/HCC DNA Resource Core since January 2017. She is the co-author of more than 45 research and review articles and co-editor of Drosophila Cells in Culture, Second Edition (Nov. 2017, Elsevier).
Stephanie is also the author of First in Fly: Drosophila Research and Biological Discovery, published by Harvard University Press in March 2018. As reviewed by the journal Nature: "Serious science, elegantly described."